These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 4331890)

  • 1. [Synthetic depot-ACTH in the treatment of obstructive bronchial diseases].
    Frank A
    Wien Med Wochenschr; 1971 Nov; 121(47):844-8. PubMed ID: 4331890
    [No Abstract]   [Full Text] [Related]  

  • 2. [Depot-ACTH in the ambulatory management of obstructive bronchial diseases].
    Frank A
    Wien Med Wochenschr; 1968 Mar; 118(12):253-6. PubMed ID: 4301963
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of chronic obstructive bronchopulmonary disease in the aged.
    Lipman WH
    West Med Med J West; 1967; 8(3):73-5. PubMed ID: 6072167
    [No Abstract]   [Full Text] [Related]  

  • 4. [Bronchial asthma. Pathogenetic assumptions - therapeutic guidelines - the significance of synthetic corticotrophin (ACTH) in its treatment (author's transl)].
    Brinkmann OH; Junge-Hülsing G
    Med Klin; 1975 Nov; 70(45):1821-6. PubMed ID: 172768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of a broncho-secretolytic in lung specialties with the help of a simple measuring method].
    Wilde W
    Arztl Forsch; 1966 Mar; 20(3):149-56. PubMed ID: 6014420
    [No Abstract]   [Full Text] [Related]  

  • 6. Solanum xanthocarpum (Kantakari) in chronic bronchitis, bronchial asthma and non-specific unproductive cough. (An experimental and clinical co-relation).
    Bector NP; Puri AS
    J Assoc Physicians India; 1971 Oct; 19(10):741-4. PubMed ID: 5132261
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hypersensitivity to synthetic ACTH (Synacthen) in patients with bronchial asthma].
    Obtulowicz K; Glowacka A
    Pol Tyg Lek; 1974 Mar; 29(12):473-4. PubMed ID: 4362422
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experiences with depot-ACTH (Tetracosactide) in bronchial obstruction].
    Kropp R
    Fortschr Med; 1976 Mar; 94(7):395-8. PubMed ID: 184022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current perspectives in the control of bronchial asthma. Synacthen Depot].
    Cardoso R
    Hospital (Rio J); 1969 Oct; 76(4):1439-54. PubMed ID: 4312092
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical trials with a new synthetic ACTH of prolonged action: Cortrosine Depot].
    Libon JC; Borlée J
    Rev Bras Med; 1971 Apr; 28(4):185-7. PubMed ID: 4330569
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies of the clinical and respiratory functional effects of a mucolytic-antibiotic preparation in chronic bronchopulmonary diseases. Controlled double-blind single code studies].
    Alberto S; Colongo PG; Brusasco L; Frigerio G
    Minerva Med; 1968 Jul; 59(53):2995-3002. PubMed ID: 5671380
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapy of chronic refractory skin diseases with synthetic ACTH, Cortrocin-depot].
    Hayakawa M
    Hifuka Kiyo; 1970 Feb; 65(1):51-61. PubMed ID: 4321317
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of ethaverin in heart diseases].
    Szám I
    Med Welt; 1973 Mar; 24(12):450-4. PubMed ID: 4144784
    [No Abstract]   [Full Text] [Related]  

  • 14. Elimination of severe height growth suppression caused by treatment with betamethasone after switching to ACTH-depot in chronic bronchial asthma.
    Moulaert AJ; Van Gemund JJ
    Helv Paediatr Acta; 1972 Apr; 21(1):55-62. PubMed ID: 4336638
    [No Abstract]   [Full Text] [Related]  

  • 15. A synthetic polypeptide--beta 1-24 corticotropin--in the depot form. II. Clinical efficacy of intermittent therapy in asthmatic patients.
    Benos SA; Koutsoukos A; Sotirakis I; Pavlatos FC
    Acta Allergol; 1969 Sep; 24(3):178-86. PubMed ID: 4314190
    [No Abstract]   [Full Text] [Related]  

  • 16. [Association of bronchodilator agents and mucolytics in aerosol therapy of chronic bronchopathies].
    Olivieri D; Brancaccio L; Bocchino M
    Handchirurgie; 1974; 29(2):138-46. PubMed ID: 4452486
    [No Abstract]   [Full Text] [Related]  

  • 17. [Synacthen depot in the treatment of some dermatological diseases].
    Mazurkiewicz W; D abrowska H
    Przegl Dermatol; 1972; 59(3):377-82. PubMed ID: 4340580
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunosuppressive treatment of bronchial asthma.
    Formgren H
    Allerg Asthma (Leipz); 1970; 16(1):36-41. PubMed ID: 4195621
    [No Abstract]   [Full Text] [Related]  

  • 19. Double-blind comparative trial of two metered bronchodilator aerosols.
    Gent PN; Hughes DT; Nisbet IG; Pearson SB; Sturgeon JG
    Br J Clin Pract; 1968 Nov; 22(11):479-81. PubMed ID: 4880250
    [No Abstract]   [Full Text] [Related]  

  • 20. [Magnetophore therapy in the combined treatment of patients with obstructive bronchial diseases and its effect on immunological reactivity].
    Molotkov VN; Kuzhko MM; Kogosova LS; Petrashenko AI
    Ter Arkh; 1984; 56(10):20-5. PubMed ID: 6523358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.